Anaconda BioMed S.L., a pre-clinical stage medical device company focused on the development of the next generation neuro-thrombectomy system for the treatment of Acute Ischemic Stroke (AIS), announced the appointment of Tudor G. Jovin, MD to join its Scientific Advisory Board (SAB). The SAB is expected to serve as a strategic network of scientific and clinical experts to Anaconda BioMed S.L., as the company progresses the development of the ANCD BRAIN® to its clinical phase. The SAB is also expected to be an integral part of the company's strategy as it continues to assess opportunities to expand its pipeline. Dr. Jovin is a Professor of Neurology and Neurosurgery, Director of the UPMC Stroke Institute and Director of the UPMC Center for Neuroendovascular Therapy.

"We are honored and gratified to have Dr. Jovin, one of the leading authorities in the field of neuro-thrombectomy agree to join our SAB," said Anaconda BioMed S.L. CEO, Dr. Ofir Arad. "Anaconda BioMed will benefit from a leading SAB to navigate our development towards a successful clinical application."

"It is a major challenge to develop a 3rd Generation Advanced Thrombectomy Device. I have been following the Anaconda BioMed's team from early stage and they developed a promising and innovative thrombectomy system," said Dr. Jovin. "I am excited to join this team and am looking forward to reaching the clinical phase".

About Anaconda BioMed, S.L.
Anaconda BioMed S.L. (www.anaconda.bio), headquartered in Barcelona, Spain, is among the world's most innovative early stage medical technology companies. The company was founded by Dr. Ofir Arad and Dr. Marc Ribó in 2015, and is developing the ANCD BRAIN®, a novel 3rd Generation Stented Aspiration Thrombectomy System for the treatment of Acute Ischemic Stroke (AIS). Every 2 seconds someone in the world is undergoing a stroke. Every 10 seconds someone in the world dies from a stroke. In the USA, there are about 690,000 annual incidences of AIS.

Source: Anaconda BioMed

Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Destacadas

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

En nuestro post hablamos sobre este interesante tipo de célula del si...

Un estudio de INCLIVA muestra el efecto ...

by INCLIVA

Han desarrollado un estudio para evaluar la correlación entre el teji...

Diapositiva de Fotos